Convocation Newsletter, Summer 2018

31 The University of Hong Kong and Guangdong Pharmaceutical University (GDPU) jointly launched the GDPU-HKU Innovations Platform in Zhongshan to collaborate on bio- and health technology, and translational medical research and development. A Satellite Branch of HKU’s Partner State Key Laboratory of Pharmaceutical Biotechnology will also be set up at GDPU. The move is of great strategic importance to HKU in terms of technology transfer and commercialisation of the University’s cutting-edge research. It is also a significant step to mark the University’s presence in the Greater Bay Area. It is estimated that China’s health and medical industry will grow to RMB 8 trillion by 2020 and RMB 16 trillion by 2030. The Platform is being established in the Torch High-Tech Industrial Development Zone, a national health technology park supported by the Ministry of Science and Technology, as well as the Guangdong and Zhongshan City governments. Speaking at the ceremony, the then Acting President and Vice-Chancellor Paul Tam said the Platform signified a new stage in the University’s effort to excel in research, innovation and technology. From left, President of Guangdong Pharmaceutical University Guo Jiao 廣東藥科大學校長郭姣教授 , the then Acting President and Vice-Chancellor Professor Paul Tam 譚廣亨 and Zhongshan Mayor Jiao Lansheng 中山市焦蘭生市長 . New Platform for BioMed Innovation HKU and Guangdong Pharmaceutical University collaborate on R&D in the Greater Bay Area Goals Three Core Units • Incubation Facility • Joint Laboratory • Technology Transfer Unit Five-year Targets • Develop into a national- level technology enterprise incubator • Host 50 spinoff companies • Incubate at least 10 HKU technologies CONVOCATION NEWSLETTER